Grove Collaborative [GROV] vs Park Ha Biological [PHH] Detailed Stock Comparison
Grove Collaborative
NYSE
Loading...
Park Ha Biological
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Grove Collaborative wins in 11 metrics, Park Ha Biological wins in 4 metrics, with 0 ties. Grove Collaborative appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Grove Collaborative | Park Ha Biological | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 0.14 | 26.34 | Grove Collaborative |
| Price-to-Book Ratio | 5.48 | 3.48 | Park Ha Biological |
| Debt-to-Equity Ratio | 201.39 | 2.15 | Park Ha Biological |
| PEG Ratio | 0.00 | N/A | N/A |
| EV/EBITDA | -4.41 | -0.71 | Grove Collaborative |
| Profit Margin (TTM) | -11.41% | 91.80% | Park Ha Biological |
| Operating Margin (TTM) | -7.93% | -1,591.00% | Grove Collaborative |
| Return on Equity | -197.15% | -729.77% | Grove Collaborative |
| Return on Assets (TTM) | -14.16% | -298.12% | Grove Collaborative |
| Free Cash Flow (TTM) | $-11.51M | $874,901 | Park Ha Biological |
| 1-Year Return | 15.67% | -88.21% | Grove Collaborative |
| Price-to-Sales Ratio (TTM) | 0.34 | 5.36 | Grove Collaborative |
| Enterprise Value | $98.74M | $13.44M | Grove Collaborative |
| EV/Revenue Ratio | 0.53 | 4.85 | Grove Collaborative |
| Gross Profit Margin (TTM) | 55.41% | N/A | N/A |
| Revenue per Share (TTM) | $5 | $0 | Grove Collaborative |
| Earnings per Share (Diluted) | $-0.59 | $-0.72 | Grove Collaborative |
| Beta (Stock Volatility) | 1.20 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Grove Collaborative vs Park Ha Biological Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Grove Collaborative | 0.00% | 0.00% | 13.14% | 14.81% | -4.32% | 9.93% |
| Park Ha Biological | -10.14% | -14.29% | -41.46% | -96.50% | -91.75% | -89.57% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Grove Collaborative | 15.67% | -94.71% | -96.90% | -96.90% | -96.90% | -96.90% |
| Park Ha Biological | -88.21% | -88.21% | -88.21% | -88.21% | -88.21% | -88.21% |
Performance & Financial Health Analysis: Grove Collaborative vs Park Ha Biological
| Metric | GROV | PHH |
|---|---|---|
| Market Information | ||
| Market Cap | $57.41M | $153.50M |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 64,990 | 945,390 |
| 90 Day Avg. Volume | 90,940 | 830,203 |
| Last Close | $1.55 | $0.43 |
| 52 Week Range | $1.02 - $1.95 | $0.43 - $41.49 |
| % from 52W High | -20.51% | -98.95% |
| All-Time High | $62.51 (Jun 20, 2022) | $41.34 (Jul 08, 2025) |
| % from All-Time High | -97.52% | -98.96% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.16% | 0.45% |
| Quarterly Earnings Growth | -0.16% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | -0.11% | 0.92% |
| Operating Margin (TTM) | -0.08% | -15.91% |
| Return on Equity (TTM) | -1.97% | -7.30% |
| Debt to Equity (MRQ) | 201.39 | 2.15 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-0.34 | $0.15 |
| Cash per Share (MRQ) | $0.25 | $0.05 |
| Operating Cash Flow (TTM) | $-4,865,000 | $1.17M |
| Levered Free Cash Flow (TTM) | $-176,250 | $5.11M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Grove Collaborative vs Park Ha Biological
| Metric | GROV | PHH |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 0.14 | 26.34 |
| Forward P/E | -6.61 | N/A |
| PEG Ratio | 0.00 | N/A |
| Price to Sales (TTM) | 0.34 | 5.36 |
| Price to Book (MRQ) | 5.48 | 3.48 |
| Market Capitalization | ||
| Market Capitalization | $57.41M | $153.50M |
| Enterprise Value | $98.74M | $13.44M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.53 | 4.85 |
| Enterprise to EBITDA | -4.41 | -0.71 |
| Risk & Other Metrics | ||
| Beta | 1.20 | N/A |
| Book Value per Share (MRQ) | $-0.34 | $0.15 |
Financial Statements Comparison: Grove Collaborative vs Park Ha Biological
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | GROV | PHH |
|---|---|---|
| Revenue/Sales | $44.03M | N/A |
| Cost of Goods Sold | $19.63M | N/A |
| Gross Profit | $24.40M | N/A |
| Research & Development | $2.21M | N/A |
| Operating Income (EBIT) | $-3.49M | N/A |
| EBITDA | $-2.89M | N/A |
| Pre-Tax Income | $-3.62M | N/A |
| Income Tax | $10,000 | N/A |
| Net Income (Profit) | $-3.63M | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | GROV | PHH |
|---|---|---|
| Cash & Equivalents | $9.61M | $547,498 |
| Total Current Assets | $38.15M | $2.84M |
| Total Current Liabilities | $25.81M | $1.52M |
| Long-Term Debt | $19.77M | $52,745 |
| Total Shareholders Equity | $13.12M | $1.51M |
| Retained Earnings | $-652.06M | $271,788 |
| Property, Plant & Equipment | $15.91M | $70,739 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | GROV | PHH |
|---|---|---|
| Operating Cash Flow | $-3.83M | N/A |
| Capital Expenditures | $-541,000 | N/A |
| Free Cash Flow | $-7.41M | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | $-15,000 | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | GROV | PHH |
|---|---|---|
| Shares Short | 1.80M | 1.02M |
| Short Ratio | 15.38 | 1.01 |
| Short % of Float | 0.08% | 0.14% |
| Average Daily Volume (10 Day) | 64,990 | 945,390 |
| Average Daily Volume (90 Day) | 90,940 | 830,203 |
| Shares Outstanding | 39.78M | 26.20M |
| Float Shares | 25.65M | 7.82M |
| % Held by Insiders | 0.29% | 0.73% |
| % Held by Institutions | 0.34% | 0.00% |
Dividend Analysis & Yield Comparison: Grove Collaborative vs Park Ha Biological
| Metric | GROV | PHH |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |